ClinicalTrials.gg
CompletedNCT05724277Updated Sep 19, 2024

The Effect of Mindfulness Meditation and Virtual Reality on Laparoscopic Cholecystectomy Patients

An interventional study of Mindfulness Meditation and Virtual Reality in Gall Bladder Disease and Laparoscopic Cholecystectomy, sponsored by Ataturk University. Completed at 1 site in Turkey. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2024-09-19.

Sponsored by Ataturk University · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
160
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

This study aims to compare the effects of the Theory of Human Caring based short-term mindfulness meditation and virtual reality on patients scheduled for laparoscopic cholecystectomy.

Read the detailed description

Anxiety, fear and sleep disorders are frequently encountered conditions in preoperative patient evaluation. Common postoperative problems include pain, sleep disturbances, nausea and vomiting. When these problems are not dealt with effectively, patient comfort and satisfaction are adversely affected, recovery time after surgery and total hospital stay are prolonged, and the time allocated to nursing care increases. Today, it has gained great importance to try to manage these problems with pharmacological and non-pharmacological evidence-based approaches. In particular, nurses need to identify possible problems in both preoperative patient evaluation and postoperative patient follow-up and produce solutions for them. Although it is stated in studies that using easy, effective and safe non-invasive methods such as meditation and virtual reality can reduce the possibility of complications, increase the comfort level of patients, improve the quality of post-surgical recovery, and thus make the surgical process successful, there is no evidence to defend its effectiveness more clearly. more based studies are needed.

02

Conditions studied

  • Gall Bladder Disease
  • Laparoscopic Cholecystectomy

Browse trials for

Keywords

  • recovery
  • mindfulness
  • meditation
  • virtual reality
  • nursing care
03

In context

Gallbladder Diseases

92 studies on the registry are indexed under Gallbladder Diseases; 19 are open to participants now.

This study's enrollment of 160 is above the median of 72 across 59 interventional studies indexed under Gallbladder Diseases.

Browse Gallbladder Diseases studies →

Lead sponsor

Ataturk University is the lead sponsor of 458 studies on the registry; 124 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 18 years old and over,
  • To undergo laparoscopic cholecystectomy operation,
  • No orientation problem,
  • Volunteering to participate in the study.

Exclusion criteria

Exclusion Criteria:

  • Conversion from laparoscopic approach to open cholecystectomy in the operating room,
  • Complications that may affect participation in the study,
  • Taking the patient to the intensive care unit after surgery,
  • Refusal to participate in the study.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
160 participants (actual)

Study arms

  • Experimental
    Mindfulness Meditation Group

    Mindfulness meditation will be applied to the patients in the Mindfulness Meditation Group for 15 minutes in the preoperative period, in both evening and morning.

    Behavioral: Mindfulness Meditation

  • Experimental
    Virtual Reality Group

    Virtual reality will be experienced to the patients in the Virtual Reality Group for 15 minutes in the preoperative period, in both evening and morning.

    Behavioral: Virtual Reality

  • No intervention
    Control Group

    The patients in the Control Group will not undergo any intervention in the preoperative period and will receive the routine nursing care of the clinic.

Interventions

  • BehavioralMindfulness Meditation

    A 15-minute mindfulness meditation will be conducted by the meditation instructor researcher.

  • BehavioralVirtual Reality

    A 10-minute virtual reality experience will be provided by using virtual reality glasses.

06

What researchers measure

Primary outcomes

  1. Mindfulness meditation practice provides a positive change in surgical fear in laparoscopic cholecystectomy patients.

    In order to evaluate surgical fear, the Surgical Fear Scale will be applied twice, before and after the mindfulness meditation practice, in the preoperative period.

    Time frame: the evening before and the morning of the surgery

  2. Mindfulness meditation practice provides a positive change in sleep quality in laparoscopic cholecystectomy patients.

    In order to evaluate sleep quality, the Richard Campbell Sleep Questionnaire will be applied in the preoperative period, in the morning of the surgery and in the postoperative period, in the morning after the surgery.

    Time frame: in the preoperative period, in the morning of the surgery and in the postoperative period, in the morning after the surgery

  3. Mindfulness meditation practice provides a positive change in nausea in laparoscopic cholecystectomy patients.

    In order to evaluate nausea, the Numerical Rating Scale will be applied five times in the postoperative period at the 0th, 2nd, 6th, 12th, and 24th hours after the surgery.

    Time frame: at postoperative 0th, 2nd, 6th, 12th and 24th hours

  4. Mindfulness meditation practice provides a positive change in pain in laparoscopic cholecystectomy patients.

    In order to evaluate the pain, the Numerical Rating Scale will be applied five times in the postoperative period at the 0th, 2nd, 6th, 12th, and 24th hours after the surgery.

    Time frame: at postoperative 0th, 2nd, 6th, 12th and 24th hours

  5. Mindfulness meditation practice provides a positive change on the quality of recovery in laparoscopic cholecystectomy patients.

    In order to evaluate the recovery quality, the Quality of Recovery-15T Questionnaire will be applied in the preoperative period and in the postoperative period.

    Time frame: in the preoperative period, evening before surgery and in the postoperative period, morning after surgery

  6. Mindfulness meditation practice provides a positive change on patient satisfaction in laparoscopic cholecystectomy patients.

    In order to evaluate patient satisfaction, Watson Caritas Patient Score will be applied once in the postoperative period.

    Time frame: at 24 hours after surgery

  7. Virtual reality practice provides a positive change in surgical fear in laparoscopic cholecystectomy patients.

    In order to evaluate surgical fear, the Surgical Fear Scale will be applied twice, before and after the virtual reality practice, in the preoperative period.

    Time frame: the evening before and the morning of the surgery

  8. Virtual reality practice provides a positive change in sleep quality in laparoscopic cholecystectomy patients.

    In order to evaluate sleep quality, the Richard Campbell Sleep Questionnaire will be applied in the preoperative period, in the morning of the surgery and in the postoperative period, in the morning after the surgery.

    Time frame: in the preoperative period, in the morning of the surgery and in the postoperative period, in the morning after the surgery

  9. Virtual reality practice provides a positive change in nausea in laparoscopic cholecystectomy patients.

    In order to evaluate nausea, the Numerical Rating Scale will be applied five times in the postoperative period at the 0th, 2nd, 6th, 12th, and 24th hours after the surgery.

    Time frame: at postoperative 0th, 2nd, 6th, 12th and 24th hours

  10. Virtual reality practice provides a positive change in pain in laparoscopic cholecystectomy patients.

    In order to evaluate pain, the Numerical Rating Scale will be applied five times in the postoperative period at the 0th, 2nd, 6th, 12th, and 24th hours after the surgery.

    Time frame: at postoperative 0th, 2nd, 6th, 12th and 24th hours

  11. Virtual reality practice provides a positive change on the quality of recovery in laparoscopic cholecystectomy patients.

    In order to evaluate the recovery quality, the Quality of Recovery-15T Questionnaire will be applied in the preoperative period and in the postoperative period.

    Time frame: in the preoperative period, evening before surgery and in the postoperative period, morning after surgery

  12. Virtual reality practice provides a positive change on patient satisfaction in laparoscopic cholecystectomy patients.

    In order to evaluate patient satisfaction, Watson Caritas Patient Score will be applied once in the postoperative period.

    Time frame: at 24 hours after surgery

Secondary outcomes

  1. Mindfulness meditation and virtual reality applications have positive effects on vital signs.

    Time frame: twice in the preoperative period and five times in the postoperative period

  2. Mindfulness meditation and virtual reality applications have positive effects on blood glucose regulation.

    Time frame: in the preoperative period, morning before surgery and in the postoperative period, morning after surgery

07

Study locations

1 site
  • Erzincan Binali Yildirim University - Mengücek Gazi Education and Research Hospital
    Erzincan, 24030, Turkey
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Dec 2022 to primary completion in Jun 2024, 17 months.

Of 32 non-industry interventional studies with no phase under Gallbladder Diseases, half reached primary completion within 13 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 26. This study's 17 months is above that.

Counting every sponsor, half of 34 studies reached it within 14 months; a quarter within 8 and three quarters within 26.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 2, 2023
First posted
Feb 13, 2023
StartActual
Dec 30, 2022
Primary completionActual
Jun 24, 2024
CompletionActual
Aug 2, 2024
Last update
Sep 19, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 19, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05724277
Lead sponsor
Ataturk University
Responsible party
Seçkin KARAKUŞ (Ataturk University, Ataturk University) — Principal investigator
First posted
Feb 13, 2023
Start date
Dec 30, 2022
Primary completion
Jun 24, 2024
Completion
Aug 2, 2024
Last update
Sep 19, 2024

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion